Navigation Links
Report says clinicians should consider economic impact of new interventions
Date:7/1/2008

ATLANTA July 2, 2008 Cancer clinicians should understand and consider the economic impact of new interventions, which often have substantial costs, according to a report appearing in the July/August issue of CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society. The report says health care budget constraints have made it necessary for clinicians to be aware of the relative costs and benefits of new interventions used in cancer screening, diagnosis, treatment, and support services for patients.

The report highlights several examples of new interventions that may help specific populations but result in increased costs. They include magnetic resonance imaging screening for breast cancer, which at $1,000 per image is ten times the cost of screening mammography; $1,800 for a positron emission tomography (PET) scan for cancer staging; $48,000 per patient per year for the use of intensity-modulated radiation therapy to treat prostate cancer; $50,000 per patient per year for trastuzumab (Herceptin) in the treatment of HER-2positive breast cancer; $1,800 per month for gefitinib (Iressa) for the treatment of lung cancer; and more than $8,000 for a 6-day course of palifermin (Kepivance) in the treatment of oral mucositis.

The report reviews the methods used for economic analyses to help clinicians understand how economic evaluations of cancer interventions are performed so they are better able to useand critiquethese evaluations. The report says clinicians should care about economic analyses for several reasons: patients are increasingly required to pay for a proportion of their medical care; expenditures need to be prioritized to determine the most reasonable use of limited health care funds; and it is important that recommended medical treatments be "good buys."

The authors write that "unless clinicians, other cancer health care providers, and cancer researchers are active participants in discussions regarding the relative costs and benefits of new interventions, others will make these cost-effectiveness conclusions. Having members of the oncology community exclude themselves from these discussions and from the process of determining costs and benefits of new cancer therapies is unlikely to be in the best interests of cancer patients."


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Related medicine news :

1. CardioDynamics Reports Second Fiscal Quarter 2008 Results, 18% Revenue Increase for First Half 2008
2. J.D. Power and Associates Reports: A Vast Majority of Southern California Indian Gaming Casino Customers Express Desire for a Smoke-Free Environment
3. 3SBio Inc. Announces Filing of Annual Report on Form 20-F
4. Spiritual effects of hallucinogens persist, Johns Hopkins researchers report
5. New HRSA Report Illustrates Success of Health Centers
6. Companies Report Success in Driving Safety Culture at Workplaces
7. Robbins & Myers Reports Record Third Quarter Results
8. American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing
9. The MedZilla Report: May 2008 Employment Outlook for Biotech/Pharma/Health
10. Climate change may challenge national security, classified report warns
11. Kewaunee Scientific Reports Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2020)... (PRWEB) , ... April 05, 2020 , ... Given the ... looking for better prices for essential services. Insurance expenses can rise to several thousand ... vehicle, driving experience and history, coverage limits, annual mileage and so on. Drivers can ...
(Date:4/2/2020)... ... April 02, 2020 , ... ... mother’s womb are encouraging their parents, grandparents, and guardians, to file a proof ... $6 billion in funds will be made available by Purdue as part of ...
(Date:4/1/2020)... ... ... Velocidy Bio ’s Dutch biotech partner, Molecular Biology Systems (MBS), has ... time for SARS-CoV-2 to eight minutes, compared to current systems that take over an ... a hundred and eighty (180) amplification runs a day, an almost ten-fold increase over ...
(Date:3/28/2020)... N.J. (PRWEB) , ... March 27, 2020 , ... ... services division of the Suntuity Group of companies, is mobilizing their drone equipment ... COVID-19 coronavirus. , By leveraging their DJI Enterprise level Matrice and Agras drones, ...
(Date:3/28/2020)... ... March 28, 2020 , ... iPatientCare, a pioneer in cloud-based ... engagement solutions has expanded the availability of telehealth services and other initiatives to ... telemedicine has a big role in fighting coronavirus . Increasing the telehealth services ...
Breaking Medicine News(10 mins):
(Date:4/5/2020)... ... April 04, 2020 , ... As the world scrambles ... supplies, diagnostics, and treatments. Shortages of such supplies are plaguing hospitals and care-givers, ... Tran & Associates supports the fight against COVID-19 and encourages every-day citizens to ...
(Date:4/2/2020)... , ... April 02, 2020 , ... ... freshman has won SignatureCare Emergency Center's 2020 Spring Semester Scholarship. , ... to the medical and healthcare field, is aimed at helping the students pay ...
(Date:4/1/2020)... , ... April 01, 2020 , ... ... subscribers to sign up today, with the first live-streaming broadcast premiering on April ... and feature a host interviewing a variety of animal keepers and veterinary hospital ...
Breaking Medicine Technology: